PortalPublikationenThe subtype-specific effects of droperidol on action potenti...

The subtype-specific effects of droperidol on action potential duration in cellular and computational models of long QT syndrome.

Standard

The subtype-specific effects of droperidol on action potential duration in cellular and computational models of long QT syndrome. / Schwoerer, Alexander; Kebernik, Julia; Ehmke, Heimo; Friederich, Patrick.

in: ANESTH ANALG, Jahrgang 111, Nr. 3, 3, 2010, S. 638-646.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Schwoerer, A, Kebernik, J, Ehmke, H & Friederich, P 2010, 'The subtype-specific effects of droperidol on action potential duration in cellular and computational models of long QT syndrome.', ANESTH ANALG, Jg. 111, Nr. 3, 3, S. 638-646. <http://www.ncbi.nlm.nih.gov/pubmed/20601449?dopt=Citation>

APA

Schwoerer, A., Kebernik, J., Ehmke, H., & Friederich, P. (2010). The subtype-specific effects of droperidol on action potential duration in cellular and computational models of long QT syndrome. ANESTH ANALG, 111(3), 638-646. [3]. http://www.ncbi.nlm.nih.gov/pubmed/20601449?dopt=Citation

Vancouver

Schwoerer A, Kebernik J, Ehmke H, Friederich P. The subtype-specific effects of droperidol on action potential duration in cellular and computational models of long QT syndrome. ANESTH ANALG. 2010;111(3):638-646. 3.

Bibtex

@article{ce3603289e5340b292d5eba1c2034f63,
title = "The subtype-specific effects of droperidol on action potential duration in cellular and computational models of long QT syndrome.",
abstract = "Droperidol is a highly potent butyrophenone used for the therapy of postoperative nausea and vomiting. Its cardiac safety in cardiovascular-healthy patients and those with long QT (LQT) syndrome is a matter of debate. In this study, we investigated whether droperidol has subtype-specific effects in cellular and computational models of LQT syndrome.",
author = "Alexander Schwoerer and Julia Kebernik and Heimo Ehmke and Patrick Friederich",
year = "2010",
language = "Deutsch",
volume = "111",
pages = "638--646",
journal = "ANESTH ANALG",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

RIS

TY - JOUR

T1 - The subtype-specific effects of droperidol on action potential duration in cellular and computational models of long QT syndrome.

AU - Schwoerer, Alexander

AU - Kebernik, Julia

AU - Ehmke, Heimo

AU - Friederich, Patrick

PY - 2010

Y1 - 2010

N2 - Droperidol is a highly potent butyrophenone used for the therapy of postoperative nausea and vomiting. Its cardiac safety in cardiovascular-healthy patients and those with long QT (LQT) syndrome is a matter of debate. In this study, we investigated whether droperidol has subtype-specific effects in cellular and computational models of LQT syndrome.

AB - Droperidol is a highly potent butyrophenone used for the therapy of postoperative nausea and vomiting. Its cardiac safety in cardiovascular-healthy patients and those with long QT (LQT) syndrome is a matter of debate. In this study, we investigated whether droperidol has subtype-specific effects in cellular and computational models of LQT syndrome.

M3 - SCORING: Zeitschriftenaufsatz

VL - 111

SP - 638

EP - 646

JO - ANESTH ANALG

JF - ANESTH ANALG

SN - 0003-2999

IS - 3

M1 - 3

ER -